Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the ...

Longest international trial on the effects of tirzepatide on weight in 700 adults with overweight or obesity and prediabetes reveals three distinct patterns of weight loss trajectories, with patients ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with T1D, and GLP-1 RA prescriptions also increased.

What is our current understanding of how differences in sex can affect obesity prevalence, comorbidities, and treatment options?

The groups were comparable in average age, duration of obesity, current smoker status, and BMI. The analysis identified three patterns of weight loss trajectories: participants in Group 1 (248 ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about the obesity drugs GLP-1/GIP ...

Waist-to-height ratio should be used in conjunction with BMI to assess overweight and obesity in children and adolescents, a ...